Omalizumab (Xolair) Lyophilized Powder from China
Omalizumab is a humanized monoclonal antibody binding IgE for severe asthma treatment. It fits HTS 3002.15.00.11 as a biotech immunological product in measured doses for retail sale.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Validate IgE specificity; declare asthma prophylactic immunological use